Table 3.

Patient demographics and baseline characteristics (n = 327)

Demographic or baseline characteristics	Results
Age distribution	31.5 ± 13.3 years (mean ± SD) 30 years (median)
Gender	52.3% (171) male 47.7% (156) female
Immunotherapy	88.6% (288) first time immunotherapy 9.2% (30) new immunotherapy after a previous complete immunotherapy 2.2% (7) change over from a different preparation
Allergological history (multiple entries)	94.5% (309) rhinitis 75.2% (246) conjunctivitis 28.4% (93) asthma 9.2% (30) neurodermatitis 2.4% (8) unspecified
Severity of ARC symptoms (in the grass pollen season preceding SLIT)
Rhinitis	87.8% (287) moderate-to-severe
Conjunctivitis	60.6% (198) moderate-to-severe
Requirement of symptomatic medication (in the grass pollen season preceding SLIT)	73.1% (239) yes 26.9% (88) no
Allergies in need of treatment (multiple entries)	100% (327) grasses 47.4% (155) cereals, rye 28.1% (92) birch 22.3% (73) alder 21.7% (71) hazel 14.4% (47) house dust mites 6.7% (22) others

ARC allergic rhinoconjunctivitis, SD standard deviation, SLIT sublingual immunotherapy